Circulating levels of il-6 and tgf-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms

HIGHLIGHTS

• who: Katarina Kopu010daliu0107 from the Institute for Oncology and Radiology of Serbia, Belgrade, Serbia have published the research work: Circulating levels of IL-6 and TGF-u03b21 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms, in the Journal: (JOURNAL)
• what: The aim of this study was to examine the possible associations between individual and clinical parameters, as well as circulating levels of IL-6 and TGF-u03b21, and the occurrence of main adverse effects of radiotherapy in patients with prostate cancer - acute and late GU and GI radiotoxicity, as . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.